The Pharmaceutical Post 1 (72/100)

The Pharmaceutical Post 1The Pharmaceutical Post 1 (72/100)The Pharmaceutical Post 1 - (1/100)The Pharmaceutical Post 1 - (2/100)The Pharmaceutical Post 1 - (3/100)The Pharmaceutical Post 1 - (4/100)The Pharmaceutical Post 1 - (5/100)The Pharmaceutical Post 1 - (6/100)The Pharmaceutical Post 1 - (7/100)The Pharmaceutical Post 1 - (8/100)The Pharmaceutical Post 1 - (9/100)The Pharmaceutical Post 1 - (10/100)The Pharmaceutical Post 1 - (11/100)The Pharmaceutical Post 1 - (12/100)The Pharmaceutical Post 1 - (13/100)The Pharmaceutical Post 1 - (14/100)The Pharmaceutical Post 1 - (15/100)The Pharmaceutical Post 1 - (16/100)The Pharmaceutical Post 1 - (17/100)The Pharmaceutical Post 1 - (18/100)The Pharmaceutical Post 1 - (19/100)The Pharmaceutical Post 1 - (20/100)The Pharmaceutical Post 1 - (21/100)The Pharmaceutical Post 1 - (22/100)The Pharmaceutical Post 1 - (23/100)The Pharmaceutical Post 1 - (24/100)The Pharmaceutical Post 1 - (25/100)The Pharmaceutical Post 1 - (26/100)The Pharmaceutical Post 1 - (27/100)The Pharmaceutical Post 1 - (28/100)The Pharmaceutical Post 1 - (29/100)The Pharmaceutical Post 1 - (30/100)The Pharmaceutical Post 1 - (31/100)The Pharmaceutical Post 1 - (32/100)The Pharmaceutical Post 1 - (33/100)The Pharmaceutical Post 1 - (34/100)The Pharmaceutical Post 1 - (35/100)The Pharmaceutical Post 1 - (36/100)The Pharmaceutical Post 1 - (37/100)The Pharmaceutical Post 1 - (38/100)The Pharmaceutical Post 1 - (39/100)The Pharmaceutical Post 1 - (40/100)The Pharmaceutical Post 1 - (41/100)The Pharmaceutical Post 1 - (42/100)The Pharmaceutical Post 1 - (43/100)The Pharmaceutical Post 1 - (44/100)The Pharmaceutical Post 1 - (45/100)The Pharmaceutical Post 1 - (46/100)The Pharmaceutical Post 1 - (47/100)The Pharmaceutical Post 1 - (48/100)The Pharmaceutical Post 1 - (49/100)The Pharmaceutical Post 1 - (50/100)The Pharmaceutical Post 1 - (51/100)The Pharmaceutical Post 1 - (52/100)The Pharmaceutical Post 1 - (53/100)The Pharmaceutical Post 1 - (54/100)The Pharmaceutical Post 1 - (55/100)The Pharmaceutical Post 1 - (56/100)The Pharmaceutical Post 1 - (57/100)The Pharmaceutical Post 1 - (58/100)The Pharmaceutical Post 1 - (59/100)The Pharmaceutical Post 1 - (60/100)The Pharmaceutical Post 1 - (61/100)The Pharmaceutical Post 1 - (62/100)The Pharmaceutical Post 1 - (63/100)The Pharmaceutical Post 1 - (64/100)The Pharmaceutical Post 1 - (65/100)The Pharmaceutical Post 1 - (66/100)The Pharmaceutical Post 1 - (67/100)The Pharmaceutical Post 1 - (68/100)The Pharmaceutical Post 1 - (69/100)The Pharmaceutical Post 1 - (70/100)The Pharmaceutical Post 1 - (71/100)The Pharmaceutical Post 1 - (72/100)The Pharmaceutical Post 1 - (73/100)The Pharmaceutical Post 1 - (74/100)The Pharmaceutical Post 1 - (75/100)The Pharmaceutical Post 1 - (76/100)The Pharmaceutical Post 1 - (77/100)The Pharmaceutical Post 1 - (78/100)The Pharmaceutical Post 1 - (79/100)The Pharmaceutical Post 1 - (80/100)The Pharmaceutical Post 1 - (81/100)The Pharmaceutical Post 1 - (82/100)The Pharmaceutical Post 1 - (83/100)The Pharmaceutical Post 1 - (84/100)The Pharmaceutical Post 1 - (85/100)The Pharmaceutical Post 1 - (86/100)The Pharmaceutical Post 1 - (87/100)The Pharmaceutical Post 1 - (88/100)The Pharmaceutical Post 1 - (89/100)The Pharmaceutical Post 1 - (90/100)The Pharmaceutical Post 1 - (91/100)The Pharmaceutical Post 1 - (92/100)The Pharmaceutical Post 1 - (93/100)The Pharmaceutical Post 1 - (94/100)The Pharmaceutical Post 1 - (95/100)The Pharmaceutical Post 1 - (96/100)The Pharmaceutical Post 1 - (97/100)The Pharmaceutical Post 1 - (98/100)The Pharmaceutical Post 1 - (99/100)The Pharmaceutical Post 1 - (100/100) Dispositifs par voie nasale / Nasal delivery devices Recipharm Inhalation sans faille, du stade de développement Solutions™ précoce à la fabrication commerciale Ces investissements permettront à des produits d’inhalation. Les services l’équipe de développement de Reci- de développement par inhalation de pharm de soutenir ses clients dans le Recipharm comprennent les études de développement de produits inhalés et stabilité pour le dossier d’enregistrement, nasaux innovants et génériques et de la caractérisation des produits et des fournir une assistance de validation et de études de bioéquivalence in vitro ainsi transfert lors du lancement de nouveaux que le développement de méthodes, la médicaments inhalables. Recipharm a validation et le soutien au transfert. récemment lancé Recipharm Inhalation Ceci est complété par des capacités de Solutions™ qui offre aux sociétés phar- fabrication commerciale fournissant maceutiques un service d’externalisation une solution de bout en bout. Crédit photo Recipharm Crédit photo Recipharm are coming to us for inhalation and nasal in the development of innovative and manufacturing of inhalation products. product development, as well as for stan- generic inhalation and nasal products and Recipharm’s inhalation development dalone SprayVIEW® analysis.” to provide validation and transfer assis- services include stability studies for the tance during the launch of new inhalable registration file, product characterization Recipharm Inhalation pharmaceuticals. Recipharm has recently and in vitro bioequivalence studies along Solutions™ launched Recipharm Inhalation Solu- with method development, validation and tions™, which offers pharmaceutical com- transfer support. This is complemented These investments will enable Recipharm’s panies a seamless outsourcing service from by commercial manufacturing capabilities development team to support its customers early development through to commercial providing an end-to-end solution. 72 The Pharmaceutical Post 01 / Janvier - 2020